Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting receptor tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of anticancer agents due to its ability to modulate signaling pathways related to tumor growth and angiogenesis. Also employed in the design of selective inhibitors for inflammatory and neurodegenerative diseases. Commonly utilized in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and metabolic stability.